Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Microsensor Monitors Hip-Implant Healing

By HospiMedica staff writers
Posted on 14 Nov 2006
A new self-powered wireless miniature sensor will help monitor the bone-healing process after hip-replacement surgery. More...


Researchers from the University of Alberta (Edmonton, Canada) used nanotechnology to build a device that can measure and compare the relative osseo-integration of a hip implant over time. This microsensor is permanently implanted within the joint and is powered kinetically, using the natural movement of the patient's body as its power source. When it is not being used, it stays dormant until a doctor asks it to start transmitting data. The device can detect and identify bone loss before it is visible on a radiograph, cutting down the need for x-rays to monitor bone functionality and reducing costs and exposure to radiation.

Careful monitoring of how the patient is healing will help patients recover as quickly as possible and resume normal activities with less chance of over-stressing the fracture during recovery and rehabilitation. It also allows the surgeon to more accurately decide when it is safe to send patients home from the hospital with their new implants.

"This microsensor not only reduces post-operation recovery time, it will also help reduce the wait time for patients needing artificial joint implants,” says Dr. Walied Moussa, a professor in the department of mechanical engineering. "The ability to monitor and quantify this healing process is critical to orthopedic surgeons in determining a patient's rehabilitation progress.”

The technology could not only monitor bone healing at the time of surgery but could also determine when implants are worn out and need to be replaced. It could be valuable throughout the patient's lifetime, used for observing and maintaining the health of the implant, with future applications in artificial knees, hip replacement, and other joint therapies.



Related Links:
University of Alberta

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.